Does trimetazidine prevent myocardial injury after percutaneous coronary intervention?
Mario Marzilli
Correspondence Cardio Thoracic Department, Division of Cardiology, University of Pisa, Via Paradisa, 256100 Pisa, Italy
Email marzilli@med.unipi.it
This article has no abstract so we have provided the first paragraph of the full text.
Myocardial damage can be caused during PCI by accumulation of atherosclerotic debris at the distal coronary bed, and by ischemia–reperfusion injury associated with balloon inflation–deflation. Even minimal myocardial damage is associated with impaired patient outcome, including an increased risk of mortality and of reinfarction during follow-up.1
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
